Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
11(3):772-81
The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin
or -20oC for long term (months)
Nampt inhibition with (E)-Daporinad (FK866) induces significant NAD+ intracellular reduction and selectively kills MM cells
Gowler PRW
Obeticholic Acid - CAS# 459789-99-2 Catalog No.:M6685-2 11(3):772-81Obeticholic Acid, CAS No. 459789 99 2, is a novel derivative of cholic acid which acts as a potent and selective FXR agonist displaying anticholeretic activity in an in vivo rat model of cholestasis. It inhibits vascular smooth muscle cell inflammation and migration as well as promotes adipocyte differentiation and regulates adipose cell function in vivo. Product information CAS Number: 459789 99 2 Molecular Weight: 420. 63 Formula: C26H44O4 Synonym: